LAM add-on ADV combination therapy or ETV monotherapy for CHB patients with suboptimal response to ADV.
Jia H, Ding F, Chen J, Zhang Y, Xiang D, Lian J, Zeng L, Yu L, Hu J, Li Y, Lu Y, Liu Y, Zheng L, Li L, Yang Y.
Jia H, et al. Among authors: zhang y.
Ann Hepatol. 2015 Mar-Apr;14(2):175-80.
Ann Hepatol. 2015.
PMID: 25671826
Free article.
Clinical Trial.